Humanized FcγR mice
Genetically modified non-human animals and methods and compositions for making and using them are provided, wherein the genetic modification comprises a deletion of the endogenous low affinity FcγR locus, and wherein the mouse is capable of expressing a functional FcRγ-chain. Genetically modified mice are described, including mice that express low affinity human FcγR genes from the endogenous FcγR locus, and wherein the mice comprise a functional FcRγ-chain. Genetically modified mice that express up to five low affinity human FcγR genes on accessory cells of the host immune system are provided.
1. A genetically modified mouse whose genome comprises at least one human low affinity FcγR α-chain gene encoding a human low affinity FcγR α-chain with a polymorphism, wherein the human low affinity FcγR α-chain gene replaces an endogenous low affinity FcγR α-chain gene, and wherein the mouse comprises a functional endogenous FcR γ-chain and functionally expresses the human low affinity FcγR α-chain gene.
2. The genetically modified mouse of claim 1 , wherein the human low affinity FcγR α-chain is a low affinity FcγRIIA α-chain.
3. The genetically modified mouse of claim 2 , wherein the polymorphism is a 131His polymorphism.
4. The genetically modified mouse of claim 2 , wherein the polymorphism is a 131Arg polymorphism.
5. The genetically modified mouse of claim 1 , wherein the human low affinity FcγR α-chain is a low affinity FcγRIIB α-chain.
6. The genetically modified mouse of claim 5 , wherein the polymorphism is a 232Ile polymorphism.
7. The genetically modified mouse of claim 5 , wherein the polymorphism is a 232Thr polymorphism.
8. The genetically modified mouse of claim 1 , wherein the human low affinity FcγR α-chain is a low affinity FcγRIIIA α-chain.
9. The genetically modified mouse of claim 8 , wherein the polymorphism is a 158Val polymorphism.
10. The genetically modified mouse of claim 8 , wherein the polymorphism is a 158Phe polymorphism.
11. A method of making a genetically modified mouse whose genome comprises a replacement of the endogenous low affinity FcγR α-chain genes with at least two human low affinity FcγR α-chain genes encoding human low affinity FcγR α-chains, the method comprising:
replacing the endogenous low affinity FcγR α-chain genes with at least two human low affinity FcγR α-chain genes encoding human low affinity FcγR α-chains,
such that the mouse comprises a functional FcR γ-chain and functionally expresses the at least two human FcγR α-chain genes.
12. The method of claim 11 , wherein the functional FcR γ-chain is an endogenous FcR γ-chain.
13. The method of claim 11 , wherein the at least two human low affinity FcγR α chain genes are selected from a human low affinity FcγRIIA, FcγRIIB, FcγRIIC, FcγRIIIA, or FcγRIIIB α chain gene.
14. The method of claim 11 , wherein the at least two human low affinity FcγR a chain genes are human low affinity FcγRIIA and FcγRIIIA α chain genes.
15. A method of making a mouse whose genome comprises a replacement of an endogenous low affinity FcγR α-chain gene with a human low affinity FcγR α-chain gene encoding a human low affinity FcγR α-chain comprising a polymorphism, the method comprising replacing an endogenous low affinity FcγR α-chain gene with a human low affinity FcγR α-chain gene encoding a human low affinity FcγR α-chain gene comprising a polymorphism, wherein the mouse further comprises a functional endogenous FcR γ-chain.
16. The method of claim 15 , wherein the human low affinity FcγR α-chain comprising a polymorphism is selected from the group consisting of a low affinity FcγRIIA α-chain comprising a 131His polymorphism, a low affinity FcγRIIA α-chain comprising a 131Arg polymorphism, a low affinity FcγRIIB α-chain comprising a 232Ile polymorphism, a low affinity FcγRIIB α-chain comprising a 232Thr polymorphism, a low affinity FcγRIIIA α-chain comprising a 158Val polymorphism, and a low affinity FcγRIIB α-chain comprising a 158Phe polymorphism.